BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 35243595)

  • 21. The Role of Simultaneous Integrated Boost in Locally Advanced Rectal Cancer Patients with Positive Lateral Pelvic Lymph Nodes.
    Meldolesi E; Chiloiro G; Giannini R; Menghi R; Persiani R; Corvari B; Coco C; Manfrida S; Ratto C; De Luca V; Sofo L; Reina S; Crucitti A; Masiello V; Dinapoli N; Valentini V; Gambacorta MA
    Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computed tomography texture analysis for the prediction of lateral pelvic lymph node metastasis of rectal cancer.
    Nakao T; Shimada M; Yoshikawa K; Tokunaga T; Nishi M; Kashihara H; Takasu C; Wada Y; Yoshimoto T
    World J Surg Oncol; 2022 Sep; 20(1):281. PubMed ID: 36057660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lateral pelvic sentinel lymph node biopsy using indocyanine green fluorescence navigation: can it be a powerful supplement tool for predicting the status of lateral pelvic lymph nodes in advanced lower rectal cancer.
    Su H; Xu Z; Bao M; Luo S; Liang J; Pei W; Guan X; Liu Z; Jiang Z; Zhang M; Zhao Z; Jin W; Zhou H
    Surg Endosc; 2023 May; 37(5):4088-4096. PubMed ID: 36997652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new technique for robotic lateral pelvic lymph node dissection for advanced low rectal cancer with emphasis on en bloc resection and inferior vesical vessel preservation.
    Ishizaki T; Mazaki J; Enomoto M; Udo R; Tago T; Kasahara K; Kuwabara H; Katsumata K; Nagakawa Y
    Surg Endosc; 2022 Oct; 36(10):7789-7793. PubMed ID: 35578045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lateral pelvic lymph node dissection can be omitted in lower rectal cancer in which the longest lateral pelvic and perirectal lymph node is less than 5 mm on MRI.
    Ogawa S; Itabashi M; Hirosawa T; Hashimoto T; Bamba Y; Kameoka S
    J Surg Oncol; 2014 Mar; 109(3):227-33. PubMed ID: 24165955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual energy CT is useful for the prediction of mesenteric and lateral pelvic lymph node metastasis in rectal cancer.
    Sato K; Morohashi H; Tsushima F; Sakamoto Y; Miura T; Fujita H; Umemura K; Suzuki T; Tsuruta S; Kura R; Ono S; Aoki M; Hakamada K
    Mol Clin Oncol; 2019 Jun; 10(6):625-630. PubMed ID: 31031979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of metastatic tumor deposit foci in rectal cancer in the lateral pelvic lymph node area.
    Yamai D; Shimada Y; Nakano M; Ozeki H; Matsumoto A; Abe K; Tajima Y; Nakano M; Ichikawa H; Sakata J; Nagai T; Ling Y; Okuda S; Watanabe G; Nogami H; Maruyama S; Takii Y; Wakai T
    Int J Clin Oncol; 2023 Oct; 28(10):1388-1397. PubMed ID: 37481501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-operative Evaluation of Lateral Pelvic Lymph Node Metastasis in Lower Rectal Cancer: Comparison of Three Different Imaging Modalities.
    Amano K; Fukuchi M; Kumamoto K; Hatano S; Ohno H; Osada H; Ishibashi K; Ishida H
    J Anus Rectum Colon; 2020; 4(1):34-40. PubMed ID: 32002474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors of rectal cancer patients with lateral pelvic lymph node metastasis.
    Fujita S; Yamamoto S; Akasu T; Moriya Y
    Hepatogastroenterology; 2012; 59(120):2494-7. PubMed ID: 22534546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of lateral pelvic lymph node metastasis in patients with locally advanced rectal cancer with preoperative chemoradiotherapy: Focus on MR imaging findings.
    Kim MJ; Hur BY; Lee ES; Park B; Joo J; Kim MJ; Park SC; Baek JY; Chang HJ; Kim DY; Oh JH
    PLoS One; 2018; 13(4):e0195815. PubMed ID: 29649321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinically enlarged lateral pelvic lymph nodes do not influence prognosis after neoadjuvant therapy and TME in stage III rectal cancer.
    Dharmarajan S; Shuai D; Fajardo AD; Birnbaum EH; Hunt SR; Mutch MG; Fleshman JW; Lin AY
    J Gastrointest Surg; 2011 Aug; 15(8):1368-74. PubMed ID: 21533959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility and safety of laparoscopic lateral pelvic lymph node dissection for locally recurrent rectal cancer and risk factors for re-recurrence.
    Ichihara M; Ikeda M; Uemura M; Miyake M; Miyazaki M; Kato T; Sekimoto M
    Asian J Endosc Surg; 2020 Oct; 13(4):489-497. PubMed ID: 31854108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequential Lateral Lymphatic Metastasis Shows Similar Oncologic Outcomes to Upward Spread in Advanced Rectal Cancer After Preoperative Chemoradiotherapy.
    Kim HJ; Choi GS; Cho SH; Kang MK; Park JS; Park SY; Kang BW; Kim JG
    Dis Colon Rectum; 2024 Mar; 67(3):359-368. PubMed ID: 37962146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is neoadjuvant chemoradiotherapy sufficient in patients with advanced rectal malignancy and positive extra-mesorectal lateral lymph nodes?
    Ahmadi N; Brown KGM; Lee P; Quinn M; Austin KKS; Solomon MJ
    Colorectal Dis; 2020 Jun; 22(6):689-693. PubMed ID: 31909851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treating patients with advanced rectal cancer and lateral pelvic lymph nodes with preoperative chemoradiotherapy based on pretreatment imaging.
    Otowa Y; Yamashita K; Kanemitsu K; Sumi Y; Yamamoto M; Kanaji S; Imanishi T; Nakamura T; Suzuki S; Tanaka K; Kakeji Y
    Onco Targets Ther; 2015; 8():3169-73. PubMed ID: 26604786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lateral lymph node and its association with distant recurrence in rectal cancer: A clue of systemic disease.
    Kim YI; Jang JK; Park IJ; Park SH; Kim JB; Park JH; Kim TW; Ro JS; Lim SB; Yu CS; Kim JC
    Surg Oncol; 2020 Dec; 35():174-181. PubMed ID: 32889250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesorectal excision with lateral lymph node dissection for mid-low rectal cancer with lateral lymph node metastasis: efficacy and prognostic analysis.
    Zhou S; Jiang Y; Liang J; Liu Q
    World J Surg Oncol; 2022 Mar; 20(1):97. PubMed ID: 35351137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possibilities for and limits of upfront surgical strategy with lateral pelvic node dissection for low rectal cancer.
    Ouchi A; Komori K; Kinoshita T; Oshiro T; Kunitomo A; Ito S; Abe T; Shimizu Y
    Jpn J Clin Oncol; 2021 Apr; 51(5):713-721. PubMed ID: 33479766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: a propensity score matching study.
    Zhou S; Jiang Y; Pei W; Liang J; Zhou Z
    BMC Cancer; 2022 Feb; 22(1):136. PubMed ID: 35109810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for lateral pelvic lymph node metastasis in patients with lower rectal cancer: a systematic review and meta-analysis.
    Zeng DX; Yang Z; Tan L; Ran MN; Liu ZL; Xiao JW
    Front Oncol; 2023; 13():1219608. PubMed ID: 37746256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.